Found: 3
Select item for more details and to access through your institution.
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC).
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3803, doi. 10.1007/s00262-023-03533-0
- By:
- Publication type:
- Article
Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1026020
- By:
- Publication type:
- Article
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK‐positive advanced non–small cell lung cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 15, p. 2611, doi. 10.1002/cncr.35293
- By:
- Publication type:
- Article